awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35127601-8E607A30-C973-481F-B35D-7E05C7B17361
Q35127601-8E607A30-C973-481F-B35D-7E05C7B17361
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35127601-8E607A30-C973-481F-B35D-7E05C7B17361
Infliximab induces increase in triglyceride levels in psoriatic arthritis patients.
P2860
Q35127601-8E607A30-C973-481F-B35D-7E05C7B17361
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35127601-8E607A30-C973-481F-B35D-7E05C7B17361
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
2e2dfb910cd23c10e64ae9b1fa1122c94815cb1d
P2860
Infliximab maintains a high degree of clinical response in patients with active psoriatic arthritis through 1 year of treatment: results from the IMPACT 2 trial.